Satish Reddy - Dr Reddys Co-Chairman of the Board

RDY -- USA Stock  

USD 35.24  0.35  1.00%

  Chairman
Mr. Satish K. Reddy serves as a Chairman of the Board of the Company. Mr. K Satish Reddy joined the company in 1993 as Executive Director and since then has held positions of increasing responsibility as Managing Director in 1997 and ViceChairman Managing Director in 2013. Mr. Reddy led the companys transition from a unifocused manufacturer of Active Pharmaceutical Ingredients to a company that moved up the value chain with a diverse product portfolio of fi nished dosage formulations. He oversaw the expansion and the establishment of a strong footprint for Dr. Reddys fi nished dosage products in Russia, CIS countries and other emerging markets. Keeping true to the legacy of the founder of the company, Dr. K Anji Reddy, Mr. K Satish Reddy drives the companys Corporationrationrate Social Responsibility initiatives
Age: 49  Chairman Since 2014      
91 40 4900 2900  http://www.drreddys.com
Reddy holds a degree in Chemical Engineering from Osmania University, Hyderabad and a Masters in Medicinal Chemistry from Purdue University, USA.

Management Efficiency

The company has Return on Asset of 5.42 % which means that on every $100 spent on asset it made $5.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.08 % implying that it generated $15.08 on every 100 dollars invested.
The company has 811.73M in debt with debt to equity (D/E) ratio of 23.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Found 9 records

CHAIRMAN Since

Joseph PapaPerrigo Company plc
2015
Michael McCallisterZoetis
2015
Jeffrey LeidenVertex Pharmaceuticals Incorpor
2012
Weidong YinSinovac Biotech Ltd
2003
Marry BrlasPerrigo Company plc
2016
Gengchen HanOrigin Agritech Limited
2016
Roy VagelosRegeneron Pharmaceuticals
1995
Yasheng YangOrigin Agritech Limited
2010
Joshua BogerVertex Pharmaceuticals Incorpor
2009

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, CEO, Managing Director
MARC KIKUCHI, CEO, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Additional Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Additional Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, CFO, Global Head - IT & BPE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, COO and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Additional Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Senior Vice President Head - Emerging Markets, Global Generics
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Currently Active Assets on Macroaxis

MA   
Purchased over 30 shares of
few hours ago
Traded for 267.15
V   
Purchased over 50 shares of
few hours ago
Traded for 173.51
EVER   
Purchased over 500 shares of
few hours ago
Traded for 21.29
AMZN   
Purchased one share of
few hours ago
Traded for 1792.5699
AU   
Purchased over 90 shares of
few hours ago
Traded for 1.84
Additionally take a look at Your Equity Center. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.
Search macroaxis.com